Salvarani C - Search Results

1

Primary central nervous system vasculitis: analysis of 101 patients.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG. Salvarani C, et al. Ann Neurol. 2007 Nov;62(5):442-51. doi: 10.1002/ana.21226. Ann Neurol. 2007. PMID: 17924545

2

Polymyalgia rheumatica and giant-cell arteritis.

Salvarani C, Cantini F, Boiardi L, Hunder GG. Salvarani C, et al. N Engl J Med. 2002 Jul 25;347(4):261-71. doi: 10.1056/NEJMra011913. N Engl J Med. 2002. PMID: 12140303 Review. No abstract available.

3

Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period.

Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Salvarani C, et al. Arthritis Rheum. 2004 Apr 15;51(2):264-8. doi: 10.1002/art.20227. Arthritis Rheum. 2004. PMID: 15077270 Free article.

4

Polymyalgia rheumatica.

Salvarani C, Cantini F, Boiardi L, Hunder GG. Salvarani C, et al. Best Pract Res Clin Rheumatol. 2004 Oct;18(5):705-22. doi: 10.1016/j.berh.2004.06.003. Best Pract Res Clin Rheumatol. 2004. PMID: 15454128 Review.

5

Giant cell arteritis: Involvement of intracranial arteries.

Salvarani C, Giannini C, Miller DV, Hunder G. Salvarani C, et al. Arthritis Rheum. 2006 Dec 15;55(6):985-9. doi: 10.1002/art.22359. Arthritis Rheum. 2006. PMID: 17139651 Free article. No abstract available.

6

Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.

Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG. Salvarani C, et al. Ann Intern Med. 2007 May 1;146(9):631-9. doi: 10.7326/0003-4819-146-9-200705010-00005. Ann Intern Med. 2007. PMID: 17470831 Clinical Trial.

7

Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritis.

Salvarani C, Hunder GG. Salvarani C, et al. Ann Intern Med. 2008 Jan 15;148(2):167-8; author reply 168. doi: 10.7326/0003-4819-148-2-200801150-00018. Ann Intern Med. 2008. PMID: 18195345 No abstract available.

8

Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment.

Salvarani C, Brown RD Jr, Calamia KT, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG. Salvarani C, et al. Arthritis Rheum. 2008 Feb 15;59(2):291-6. doi: 10.1002/art.23337. Arthritis Rheum. 2008. PMID: 18240197 Free article. No abstract available.

9

Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG. Salvarani C, et al. Arthritis Rheum. 2008 Feb;58(2):595-603. doi: 10.1002/art.23300. Arthritis Rheum. 2008. PMID: 18240248 Free article.

10

Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?

Salvarani C, Pipitone N, Boiardi L, Hunder GG. Salvarani C, et al. Ann Rheum Dis. 2008 May;67(5):577-9. doi: 10.1136/ard.2007.086330. Ann Rheum Dis. 2008. PMID: 18408108 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

812 results

Search Page